## CHD: Church & Dwight Co., Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -0.1% below STRENGTH zone (4.0-10.0%); PEG 1.97 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (57% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($81.08)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Citi Upgrades Church & Dwight (CHD) to Neutral as Sales Outlook Improves**
- Source: Yahoo Finance UK | 20251230T200742 | Somewhat-Bullish | Relevance: 100%
- Citi upgraded Church & Dwight (CHD) to Neutral from Sell and increased its price target to $87, citing an improved sales outlook for 2026 due to easier year-over-year comparisons. The company recently agreed to sell its VitaFusion and Lâ€™il Critters brands to Piping Rock Health Products, a move expected to incur a one-time, after-tax charge in Q4 2025. Church & Dwight is a leading producer of sodium bicarbonate and a wide range of personal care and household products.

**2. Allspring Global Investments Holdings LLC Has $291.66 Million Stock Holdings in Church & Dwight Co., Inc. $CHD**
- Source: MarketBeat | 20251231T084803 | Somewhat-Bullish | Relevance: 95%
- Allspring Global Investments Holdings LLC increased its stake in Church & Dwight Co., Inc. (NYSE:CHD) by 1.5% in the third quarter, bringing their total holdings to 3,317,338 shares valued at $291.66 million, representing approximately 1.36% of the company. Church & Dwight beat Q3 earnings estimates with EPS of $0.81 and revenue of $1.59 billion, and has provided guidance for Q4 2025 EPS of $0.83 and FY2025 EPS of $3.49. The company also declared a quarterly dividend of $0.295 per share, resulting in an annualized dividend of $1.18 and a yield of 1.4%.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $87 | $85 | +2% |
| 2025-12-17 | Jefferies | $102 | $97 | +5% |
| 2025-12-10 | Deutsche Bank | $100 | $102 | -2% |
| 2025-12-04 | Argus Research | $102 | $110 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | up | Neutral |
| 2025-12-17 | Jefferies | up | Buy |
| 2025-12-10 | Deutsche Bank | main | Buy |
| 2025-12-04 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 15 ($0.03M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-2.1%)
- Blackrock Inc.: 9.3% (-1.1%)
- State Street Corpora: 5.7% (+2.4%)
- JPMORGAN CHASE & CO: 5.1% (+105.9%)
- Capital Internationa: 4.0% (+0.5%)

### Key Risks

1. Long-term trend broken: trading 10.1% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.97 elevated, pricing in significant growth expectations. Forward P/E 22.4x stretched relative to 7% growth. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.4B |
| Beta | 0.45 |
| 52W Range | $81.33 - $116.46 |
| Short Interest | 4.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.97 |
| Forward P/E | 22.4 |
| Current P/E | 24.0 |
| YoY Growth | 7.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -0.1% (minimal 5-day change). Below STRENGTH zone by 4.1pp (needs >4.0% for momentum thesis). Below SMA200 (0.90x), long-term trend not supportive. RSI neutral at 46. Volume at 57% of 20MA suggests lack of conviction. OFD pattern: -MUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.11% (CS: 46) | Neutral |
| RSI_14 | 45.5 | Neutral |
| MACD Histogram | 0.02 | Bullish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 0.990x | Below |
| vs SMA200 | 0.899x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $83.84
- **Stop Loss:** $81.08 (3.3% risk)
- **Target:** $86.60 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 434
- **Position Value:** $36,386.56
- **Portfolio %:** 36.39%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with mixed signals requiring caution. VIX at 14.95 suggests calm markets, but record repo borrowing and narrowing breadth (51.4%) indicate stress beneath the surface. Positive yield curve (+62bps) and stable economic data support risk assets, but year-end dynamics mask true liquidity conditions.*

### Earnings

**Next:** 2026-01-30 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.74 | $0.81 | +9.9% |
| 2025Q2 | $0.86 | $0.94 | +9.5% |
| 2025Q1 | $0.90 | $0.91 | +1.4% |
| 2024Q4 | $0.77 | $0.77 | +0.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*